Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acid Reflux Disease
Researchers at Emory University target acid reflux disease
July 1st, 2008
According to a study from the United States, "Background and objectives Reflux esophagitis is a common disease. Erosive reflux esophagitis is a more advanced stage of reflux esophagitis." "Although death from reflux disease is uncommon, significant morbidity and mortality from complications, such as esophageal ulcer, stricture, and cancer, are not uncommon. Proton pump inhibitors are the popular medication for reflux esophagitis. The objective of this study was to determine the efficacy and safety of continuous intravenous infusion of pantoprazole in the treatment of severe erosive esophagitis. From February 2005 to November 2006, all patients with grade 4 erosive...
Source: Cancer Weekly (2008-07-01)
|
